ABSTRACT
OBJECTIVES: Femoral head osteonecrosis (ON) is a serious complication of steroid administration. We evaluated bone marrow transplantation (BMT) for preventing corticosteroid-induced ON. METHODS: Rabbits, injected with methylprednisolone (MPSL; 20 mg/kg), were divided into four groups: (i) MPSL alone; MPSL injection only, (ii) MPSL+needling; 2 days after MPSL injection, a hole (1.2 mm diameter) was drilled from the outer cortex 2.5 cm distal to the proximal end of the greater trochanter, (iii) MPSL+saline; 2 days after MPSL injection, 2 ml saline was injected directly into the bone marrow cavity, and (iv) MPSL+BMT; 2 days after MPSL injection, 1 x 10(7)/2 ml bone marrow cells (BMCs) were injected directly into the bone marrow cavity. Platelets, fibrinogen, prothrombin time and total cholesterol in peripheral blood were measured before and after treatment. Tissues were stained with haematoxylin and eosion and terminal deoxynucleotidyl-mediated deoxyuridine triphosphate nick-end labelling stain and immunostained for VEGF, while cell proliferation and viability of whole BMCs in the femur were analysed by cell cycle analysis and [(3)H]-thymidine uptake. RESULTS: The ON incidence in rabbits treated with MPSL alone, MPSL+needling and MPSL+saline was 72.7, 70.0 and 66.7%, respectively, while in the MPSL+BMT group, the incidence was 0%. Serological findings in the MPSL+BMT group were almost normalized. VEGF and TUNEL staining were reduced in the MPSL+BMT group compared with all other groups. There were significantly fewer BMCs in G1 phase from the MPSL+BMT group than the other groups, while uptake of [(3)H]-thymidine was significantly increased. CONCLUSION: Direct injection of autologous BMCs into femurs prevents corticosteroid-induced ON following treatment with high-dose, short-term steroids.
Subject(s)
Bone Marrow Transplantation/methods , Femur Head Necrosis/chemically induced , Femur Head Necrosis/prevention & control , Glucocorticoids/adverse effects , Methylprednisolone/adverse effects , Animals , Apoptosis , Blood Coagulation , Cell Cycle/drug effects , Drug Administration Schedule , Female , Femur Head/pathology , Femur Head Necrosis/pathology , Fibrinolysis , In Situ Nick-End Labeling , Injections , Models, Animal , Osteoblasts/transplantation , Osteoclasts/transplantation , Rabbits , Transplantation, Autologous , Vascular Endothelial Growth Factor A/analysisABSTRACT
After partial hepatectomy, the liver is capable of complete restoration to its normal size. The extracellular matrix, which surrounds the cells, plays important roles in this regeneration. Glycosaminoglycans (GAGs), which are components of the extracellular matrix, interact with several other matrix components and growth factors, and are involved in hepatocyte growth. In this study, the content of heparan sulfate, a major GAG in rat liver, reached a minimum at 12 hours after partial hepatectomy. Galactosyltransferase-I activity, related to the synthesis of GAGs, and sialyltransferase activity, related to the synthesis of glycoconjugates, reached a minimum at 6 hours. The serum and liver contents of hyaluronic acid reached a maximum at 1 day and returned gradually to their preoperative levels. These results suggest that polysaccharide synthesis was decreased in the Golgi apparatus of hepatocytes at the beginning of regeneration, and that hyaluronic acid degradation decreased in the lysosomes of hepatocytes. The ability to synthesize polysaccharides recovered ahead of the ability to degrade hyaluronic acid. The changes in these GAGs with time in the early regeneration period might play an important role in organ regeneration.
Subject(s)
Galactosyltransferases/metabolism , Glycosaminoglycans/metabolism , Liver Regeneration/physiology , Liver/enzymology , Sialyltransferases/metabolism , Animals , Chromatography, High Pressure Liquid , Electrophoresis, Gel, Two-Dimensional , Fluorescent Dyes , Hepatectomy , Hyaluronic Acid/blood , Hyaluronic Acid/metabolism , Male , Rats , Rats, WistarABSTRACT
Prodigiosin, prodigiosin 25-C, and metacycloprodigiosin all strongly inhibited the acidification activity of (H(+)+K(+))-ATPase on membrane vesicles from hog gastric mucosa (IC(50) = 32 to 103 pmol/mg protein). But, the prodigiosins, unlike omeprazole, showed little inhibitory effect on K(+)-dependent ATPase (K(+)-ATPase) activity, although at higher concentrations they inhibited K(+)-ATPase activity with an IC(50) of 1.5 to 3.0 microM. Furthermore, the inhibitory effect of the prodigiosins was rapid and completely reversible unlike that of omeprazole, and the mode of inhibition was non-competitive with respect to ATP. Hog gastric (H(+)+K(+))-ATPase itself showed an absolute requirement of halide (effectively, chloride) for acidification activity. Prodigiosins also showed a chloride requirement for inhibition of vesicular acidification, and quickly reversed the acidification of vesicular pH to neutrality even in the presence of N, N'-dicyclohexylcarbodiimide (DCCD), showing their ionophoric nature of acidification inhibitory activity. In fact, tributyltin chloride (TBT, an OH(-)/Cl(-) exchange ionophore) also inhibited vesicular acidification, but it inhibited K(+)-ATPase activity too. Finally, the prodigiosins inhibited the acid secretion from parietal cells isolated from rabbit gastric mucosa. These results suggest that prodigiosins are potent reversible uncouplers of (H(+)+K(+))-ATPase that inhibit gastric acid secretion.
Subject(s)
Anti-Bacterial Agents/pharmacology , Gastric Mucosa/drug effects , H(+)-K(+)-Exchanging ATPase/metabolism , Prodigiosin/pharmacology , Adenosine Triphosphate/metabolism , Animals , Biological Transport/drug effects , Chlorides/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Gastric Acid/metabolism , Gastric Mucosa/enzymology , Gastric Mucosa/metabolism , Hydrogen-Ion Concentration , Hydrolysis , In Vitro Techniques , Omeprazole/pharmacology , Proton Pump Inhibitors , Rabbits , Secretory Vesicles/drug effects , SwineABSTRACT
Prodigiosin, metacycloprodigiosin, and prodigiosin 25-C all inhibited the acidification activity of submitochondrial and bacterial (Escherichia coli) F-ATPases (FoF1-ATPases) strongly (IC50 = 20-30 and 24-30 pmol/mg protein, respectively), without affecting significantly the ATP hydrolysis activity. Their effect on the acidification activity was rapid and reversible, showing non-competitive apparent Ki values of the order of nM to sub-nM. However, unlike FCCP (an ordinary uncoupler of oxidative phosphorylation), they showed no protonophoric activity, as demonstrated by the absence of acceleration of ATP hydrolysis. Prodigiosins also inhibited the acidification of proteoliposomes reconstituted from phospholipids and purified F-ATPase of E. coli, suggesting that their acidification-inhibitory effect is not due to the inhibition of anion channels. They did not, however, inhibit the ATP-dependent formation of membrane potential of F-ATPase vesicles. Furthermore, they inhibited and quickly reversed acidification by F-ATPase only in the presence of chloride, and not in the presence of gluconate anion. Finally, they induced swelling of liposomes and submitochondrial particles in isotonic solution of ammonium chloride but not ammonium gluconate, suggesting that intravesicular entry of Cl- is promoted by prodigiosins. These results suggest that prodigiosins uncouple F-ATPases through promotion of H+/Cl- symport (or OH-/Cl- exchange) across vesicular membranes.
Subject(s)
Antiporters/metabolism , Escherichia coli/drug effects , Mitochondria, Liver/drug effects , Prodigiosin/pharmacology , Proton-Translocating ATPases/metabolism , Uncoupling Agents/pharmacology , Animals , Escherichia coli/enzymology , Liposomes , Mitochondria, Liver/enzymology , Rats , Rats, WistarABSTRACT
We reported previously [Kataoka, Muroi, Ohkuma, Waritani, Magae, Takatsuki, Kondo, Yamasaki and Nagai (1995) FEBS Lett. 359, 53-59] that prodigiosin 25-C (one of the red pigments of the prodigiosin group produced by micro-organisms like Streptomyces and Serratia) uncoupled vacuolar H+-ATPase, inhibited vacuolar acidification and affected glycoprotein processing. In the present study we show that prodigiosin, metacycloprodigiosin and prodigiosin 25-C, all raise intralysosomal pH through inhibition of lysosomal acidification driven by vacuolar-type (V-)ATPase without inhibiting ATP hydrolysis in a dose-dependent manner with IC50 values of 30-120 pmol/mg of protein. The inhibition against lysosomal acidification was quick and reversible, showing kinetics of simple non-competitive (for ATP) inhibition. However, the prodigiosins neither raised the internal pH of isolated lysosomes nor showed ionophoric activity against H+ or K+ at concentrations where they strongly inhibited lysosomal acidification. They required Cl- for their acidification inhibitory activity even when driven in the presence of K+ and valinomycin, suggesting that their target is not anion (chloride) channel(s). In fact, the prodigiosins inhibited acidification of proteoliposomes devoid of anion channels that were reconstituted from lysosomal vacuolar-type (V-)ATPase and Escherichia coli phospholipids. However, they did not inhibit the formation of an inside-positive membrane potential driven by lysosomal V-ATPase. Instead, they caused quick reversal of acidified pH driven by lysosomal V-ATPase and, in acidic buffer, produced quick acidification of lysosomal pH, both only in the presence of Cl-. In addition, they induced swelling of liposomes and erythrocytes in iso-osmotic ammonium salt of chloride but not of gluconate, suggesting the promotion of Cl- entry by prodigiosins. These results suggest that prodigiosins facilitate the symport of H+ with Cl- (or exchange of OH- with Cl-) through lysosomal membranes, resulting in uncoupling of vacuolar H+-ATPase.
Subject(s)
Lysosomes/drug effects , Lysosomes/metabolism , Prodigiosin/pharmacology , Proton-Translocating ATPases/metabolism , Uncoupling Agents/pharmacology , Vacuolar Proton-Translocating ATPases , Adenosine Triphosphate/metabolism , Animals , Antiporters/metabolism , Chlorides/metabolism , Erythrocytes/drug effects , Erythrocytes/metabolism , Humans , Hydrogen/metabolism , Hydrogen-Ion Concentration , In Vitro Techniques , Ion Transport/drug effects , Kinetics , Male , Prodigiosin/analogs & derivatives , Proteolipids/metabolism , Rats , Rats, WistarABSTRACT
Human skin fibroblasts were incubated in the presence of 4-methylumbelliferyl-beta-D-xyloside (Xyl-MU). The culture medium was recovered and Xyl-MU derivatives which were initiated by the Xyl-MU acting as a primer were purified. As a result, a novel Xyl-MU derivative was isolated, in addition to previously reported Xyl-MU derivatives such as glycosaminoglycan-MU, Gal-Gal-Xyl-MU, Gal-Xyl-MU, SA-Gal-Xyl-MU, Xyl-Xyl-MU, GlcA-Xyl-MU, and sulfate-GlcA-Xyl-MU. This Xyl-MU derivative was subjected to carbohydrate composition analysis, enzyme digestion, ion-spray mass spectrometric analysis, and Smith degradation. The results indicated that it was sulfate- O -3-Xyl-MU. When Xyl-MU was incubated with [35S]PAPS using a homogenate prepared from the same cultured skin fibroblasts, [35S]sulfate- O -3-Xyl-MU was produced. Moreover, when Xyl-MU was incubated with UDP-[3H]Gal, [3H]galactose was transferred to Xyl-MU, but when sulfate- O -3-Xyl-MU was incubated with UDP-[3H]Gal, [3H]galactose was not transferred. These results indicate that chain elongation from Xyl-MU is inhibited by sulfation of Xyl-MU, and that Xyl-MU sulfation is involved in the control of Xyl-MU-initiated glycosaminoglycan biosynthesis.
Subject(s)
Glycosaminoglycans/biosynthesis , Hymecromone/analogs & derivatives , Hymecromone/metabolism , Skin/metabolism , Xylose/analogs & derivatives , Cells, Cultured , Chromatography, High Pressure Liquid , Fibroblasts/cytology , Fibroblasts/metabolism , Humans , Hymecromone/isolation & purification , Mass Spectrometry , Skin/cytology , Xylose/isolation & purification , Xylose/metabolismABSTRACT
Various oligosaccharides from hyaluronic acid, which have glucuronic acid or N- acetylglucosamine at the nonreducing terminal, were prepared by digestion with a combination of testicular hyaluronidase and beta-glucuronidase. These oligo saccharides were analyzed by negative-mode ion-spray mass spectrometry (MS) with an atmospheric pressure ion source. Introduction of collisionally activated dissociation tandem mass spectrometry (CAD-MS/MS) produced ions derived from cleavage of the glycosidic bonds, allowing the structure to be analyzed. The CAD-MS/MS spectrum showed an intense and characteristic fragment ion at m/z 193 for oligosaccharides having glucuronic acid at the nonreducing terminal. On the other hand, this ion was not observed in the spectra of oligosaccharides having N- acetylglucosamine at the nonreducing terminal. Therefore, the fragmentation pattern revealed by CAD-MS/MS provides useful information for distinguishing glucuronic acid and N- acetylglucosamine at the nonreducing terminal of oligosaccharides derived from hyaluronic acid and other glycosaminoglycans. This ion-spray CAD-MS/MS technique was also applied successfully to the characterization of glycosaminoglycans reconstructed by glycotechnology.
Subject(s)
Glycosaminoglycans/chemistry , Hyaluronic Acid/chemistry , Oligosaccharides/chemistry , Animals , Carbohydrate Sequence , Carbohydrates/analysis , Cattle , Escherichia coli/enzymology , Glucuronidase/metabolism , Humans , Hyaluronic Acid/isolation & purification , Hyaluronoglucosaminidase/metabolism , Male , Mass Spectrometry/methods , Molecular Sequence Data , Oligosaccharides/isolation & purification , Spectrometry, Mass, Secondary Ion/methods , Testis/enzymology , Umbilical Cord/chemistryABSTRACT
The effects of dimethylsulfoxide used as a solvent on the suppressive effects of lidocaine on synaptic transmission were examined in the bullfrog sympathetic ganglion. Compound action potentials (CAP) in response to orthodromic stimulation of the presynaptic nerve trunk were recorded extracellularly from the bullfrog sympathetic ganglion. Application of lidocaine dissolved in normal Ringer's solution significantly decreased the amplitude of CAP. This suppressive effect of lidocaine was markedly potentiated when lidocaine was dissolved in 0.1% DMSO solution. A similar potentiating effect of DMSO was observed on the suppressive action of lidocaine on acetylcholine (ACh)-induced depolarizing response recorded intracellularly from the sympathetic ganglion cell. On the other hand, 0.1% DMSO solution alone had no effect on synaptic transmission, resting membrane potential, resting membrane resistance or ACh receptor activity. The present findings suggest that DMSO as solvent should be used carefully because of its potentiating effect on drug actions. Since the effect of lidocaine is due to the suppression of nicotinic ACh receptor at the postsynaptic membrane, DMSO may allosterically act on the nicotinic ACh receptor causing an increase in efficacy of lidocaine.
Subject(s)
Dimethyl Sulfoxide/pharmacology , Ganglia, Sympathetic/drug effects , Lidocaine/pharmacology , Synaptic Transmission/drug effects , Acetylcholine/pharmacology , Animals , Dose-Response Relationship, Drug , Rana catesbeianaABSTRACT
The usefulness of iontophoretic anesthesia with 10% lidocaine was evaluated on insertion of venous catheters on 38 blood donors in a blood bank and on 41 patients in a hospital, after the arm was charged for 3, 6 or 9 minutes with 1.5 mA of electricity by using a hand-made iontophoretic anesthesia apparatus. In the blood donor group, the pain-relief effect was observed in 25% of donors after charging for 3 min; in 68% after 6 min; and in 93% after 9 min. In the patient group, anesthesia was observed in 14% of patients after 6 min and in 65% after 9 min though the effect was observed in 81% after 6 min and in 65% after 9 min. But only 45-48% of subjects in both groups requested the anesthesia after charging for either 6 or 9 min. This suggests that the duration for 9 min was not liked by the subject despite the pain on insertion. Therefore it is concluded that the charging duration of the iontophoresis must be shorter for this method to become useful as local anesthesia.